KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CRISPR Therapeutics AG (CRSP) Exchange Rate Effect (2016 - 2025)

CRISPR Therapeutics AG (CRSP) has disclosed Exchange Rate Effect for 11 consecutive years, with $1000.0 as the latest value for Q4 2025.

  • Quarterly Exchange Rate Effect rose 101.15% to $1000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $95000.0 through Dec 2025, up 552.38% year-over-year, with the annual reading at $95000.0 for FY2025, 552.38% up from the prior year.
  • Exchange Rate Effect hit $1000.0 in Q4 2025 for CRISPR Therapeutics AG, up from -$27000.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $115000.0 in Q4 2022 to a low of -$100000.0 in Q3 2022.
  • Historically, Exchange Rate Effect has averaged $2800.0 across 5 years, with a median of $2500.0 in 2021.
  • Biggest five-year swings in Exchange Rate Effect: plummeted 1460.0% in 2022 and later surged 3900.0% in 2025.
  • Year by year, Exchange Rate Effect stood at $3000.0 in 2021, then soared by 3733.33% to $115000.0 in 2022, then crashed by 46.96% to $61000.0 in 2023, then crashed by 242.62% to -$87000.0 in 2024, then skyrocketed by 101.15% to $1000.0 in 2025.
  • Business Quant data shows Exchange Rate Effect for CRSP at $1000.0 in Q4 2025, -$27000.0 in Q3 2025, and $80000.0 in Q2 2025.